Who is sponsoring NCT05422131?

NCT05422131 is sponsored by Saladax Biomedical, Inc..

What drugs are being tested in NCT05422131?

Interventions in NCT05422131: MyCare Insite Clozapine Test.

What condition does NCT05422131 study?

NCT05422131 studies Patients Prescribed Clozapine.

Is NCT05422131 still recruiting?

NCT05422131 is currently completed. Last updated 18 May 2023.

Last reviewed 2023-05-18 · How we verify

NCT05422131

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clozapine Therapy Sample Collection - Method Comparison Study

Completed Last updated 18 May 2023

What this trial tests

trial testing MyCare Insite Clozapine Test in Patients Prescribed Clozapine in 153 participants. Completed in 16 May 2023.

Timeline

12 November 2022

Primary endpoint
25 January 2023

16 May 2023

Quick facts

Lead sponsor	Saladax Biomedical, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	153
Start date	12 November 2022
Primary completion	25 January 2023
Estimated completion	16 May 2023
Sites	1 location across United States

Drugs / interventions tested

MyCare Insite Clozapine Test

Conditions studied

Patients Prescribed Clozapine — all drugs for Patients Prescribed Clozapine →

Sponsor

Saladax Biomedical, Inc.

Who can join

21 and older, any sex, with Patients Prescribed Clozapine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The method comparison study involves capillary fingerstick blood, venous serum, and venous K2EDTA blood sample collection from human subjects receiving clozapine treatment and their clozapine concentration measurement using a validated mass spectrometry method, the automated immunoassay MyCare Psychiatry Clozapine Assay Kit manufactured by SBI, and the point of care MyCare Insite Clozapine Test manufactured by SBI. Clozapine measurements obtained using the MyCare Insite Clozapine Test are intended for investigational purposes only and shall not be used in the management of patients receiving clozapine therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Saladax Biomedical, Inc. trials

Trials by the same sponsor.

NCT05711732 — Busulfan Sample Collection Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05422131 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saladax Biomedical, Inc.
Last refreshed: 18 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05422131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing